LGCRX
Price
$16.00
Change
+$0.21 (+1.33%)
Updated
Apr 23 closing price
Net Assets
131.28M
RWIHX
Price
$61.99
Change
+$0.82 (+1.34%)
Updated
Apr 23 closing price
Net Assets
117.94B
Ad is loading...

LGCRX vs RWIHX

Header iconLGCRX vs RWIHX Comparison
Open Charts LGCRX vs RWIHXBanner chart's image
Lord Abbett Global Equity R3
Price$16.00
Change+$0.21 (+1.33%)
VolumeN/A
Net Assets131.28M
American Funds Capital World Gr&Inc R5E
Price$61.99
Change+$0.82 (+1.34%)
VolumeN/A
Net Assets117.94B
LGCRX vs RWIHX Comparison Chart
Loading...
View a ticker or compare two or three
VS
LGCRX vs. RWIHX commentary
Apr 25, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is LGCRX is a Buy and RWIHX is a Buy.

Ad is loading...
FUNDAMENTALS
Fundamentals
RWIHX has more cash in the bank: 118B vs. LGCRX (131M). RWIHX pays higher dividends than LGCRX: RWIHX (1.84) vs LGCRX (0.17). LGCRX was incepted earlier than RWIHX: LGCRX (8 years) vs RWIHX (9 years). LGCRX (2.80) is less costly to investors than RWIHX (0.56). LGCRX is a more actively managed with annual turnover of: 41.00 vs. RWIHX (27.00). LGCRX has a lower initial minimum investment than RWIHX: LGCRX (0) vs RWIHX (250). LGCRX annual gain was more profitable for investors over the last year : 4.39 vs. RWIHX (-1.26). LGCRX return over 5 years is better than : 57.76 vs. RWIHX (47.72).
LGCRXRWIHXLGCRX / RWIHX
Total Expense Ratio1.150.56205%
Annual Report Gross Expense Ratio2.800.56500%
Fund Existence8 years9 years-
Gain YTD-4.419-3.178139%
Front LoadN/AN/A-
Min. Initial Investment0250-
Min. Initial Investment IRAN/AN/A-
Net Assets131M118B0%
Annual Yield % from dividends0.171.849%
Returns for 1 year4.39-1.26-348%
Returns for 3 years27.8115.32182%
Returns for 5 years57.7647.72121%
Returns for 10 yearsN/AN/A-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
LCTX0.470.04
+9.82%
Lineage Cell Therapeutics
DUO0.240.01
+3.86%
Fangdd Network Group Ltd
SNDL1.410.02
+1.79%
SNDL
PRK147.911.52
+1.04%
Park National Corp
ASND158.14-0.99
-0.62%
Ascendis Pharma A/S